Blood marker study for people not eligible for Alzheimer's prevention trials
Part of Brain & nervous system, Mental health clinical trials.
This study looks at blood markers in people who were part of an early Alzheimer's prevention study but did not qualify for it because their amyloid levels were too low. It aims to understand brain changes and possibly find ways to detect Alzheimer's even earlier.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You previously signed up for an early Alzheimer's prevention study (like AHEAD 3-45 or A4).
- You were not eligible for that study because your amyloid levels were too low.
- You are not currently taking any FDA-approved Alzheimer's medication and have not taken one in the past.
- You are not enrolled in any other investigational drug study right now.
- You can see, hear, and read well enough in English or Spanish to do study tests.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a treatment targeting tau protein buildup in the brain for people with early Alzheimer's. You may join if you have memory or thinking changes but are still living independently, and brain scans show both amyloid and tau clumps.
This study enrolls people with no memory impairment, mild memory problems, or mild Alzheimer’s dementia to test how brain scans and cognitive tests relate to Alzheimer’s disease. It may help by contributing to better early diagnosis and by letting you see whether you fit into the study’s imaging and blood-test pathway.
This study looks for brain/biological “signals” (biomarkers) that may identify Alzheimer’s disease earlier, including stages before clear symptoms. You may be followed for about 5 years, with repeated memory and thinking testing to see how these signs relate to future diagnosis.
This study is looking for a simple blood test to help diagnose Alzheimer's disease earlier and more accurately in a primary care setting. If you are 55 or older with memory concerns, participating could help improve diagnostic methods and may lead to earlier support and treatment.
This study is testing whether a simple blood draw can help spot early signs of Alzheimer's disease. It aims to include people from diverse backgrounds who do not currently have memory problems, which may help make early detection more accessible for everyone.
This study looks at how to better predict and understand Alzheimer's disease by using advanced brain scans and spinal fluid tests. It aims to find ways to identify people who stay healthy longer despite risk factors.
Hear when a new Preclinical Alzheimer's Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.